By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants who have Human Immunodeficiency Virus (HIV) testing
Timeframe: baseline
Number of participants who have Sexually Transmitted Infection (STI) testing
Timeframe: baseline
Number of participants who have Hepatitis C Virus (HCV) testing
Timeframe: baseline
Number of participants who have HIV testing
Timeframe: immediate post-intervention (12 months post-baseline)
Number of participants who have STI testing
Timeframe: immediate post-intervention (12 months post-baseline)
Number of participants who have HCV testing
Timeframe: immediate post-intervention (12 months post-baseline)
Number of participants who have HIV testing
Timeframe: 12-month follow-up (24 months post-baseline)
Number of participants who have STI testing
Timeframe: 12-month follow-up (24 months post-baseline)
Number of participants who have HCV testing
Timeframe: 12-month follow-up (24 months post-baseline)